Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Return on Assets (2023 - 2026)

Indivior Pharmaceuticals has reported Return on Assets over the past 4 years, most recently at 0.0% for Q1 2026.

  • For Q1 2026, Return on Assets changed 0.0% year-over-year to 0.0%; the TTM value through Mar 2026 reached 0.0%, changed 0.0%, while the annual FY2025 figure was 0.0%, 0.0% changed from the prior year.
  • Return on Assets for Q1 2026 was 0.0% at Indivior Pharmaceuticals, up from 0.0% in the prior quarter.
  • Over five years, Return on Assets peaked at 0.0% in Q1 2026 and troughed at 0.0% in Q3 2023.
  • A 4-year average of 0.0% and a median of 0.0% in 2023 define the central range for Return on Assets.
  • On a YoY basis, Return on Assets climbed as much as 0bps in 2024 and fell as far as 0bps in 2024.
  • Year by year, Return on Assets stood at 0.0% in 2023, then skyrocketed by 554bps to 0.0% in 2024, then surged by 3087bps to 0.0% in 2025, then soared by 30bps to 0.0% in 2026.
  • Business Quant data shows Return on Assets for INDV at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.